Obesity and metabolic syndrome are considered risk factors for AF, with meta-analyses showing increased AF incidence with elevated total cholesterol levels.[50] The correlation between cyclic adenosine phosphate and AF, as discussed earlier, suggests PDE4D as a potential target for activating the cAMP signaling pathway. This evidence concerns the gene PDE4D and obesity due to melanocortin 4 receptor deficiency.